PORTLAND, Ore., Feb. 11, 2026 /PRNewswire/ — Allied Market Research published a report, titled, “Kidney Dialysis Market by Type (Hemodialysis and Peritoneal Dialysis), Product and Service (Equipment, Consumables and Services), and End User (In-Center Dialysis and Home Dialysis): Global Opportunity Analysis and Industry Forecast, 2024-2033″. According to the report, the kidney dialysis market was valued at $79.6 billion in 2023, and is estimated to reach $149.7 billion by 2033, growing at a CAGR of 6.5% from 2024 to 2033.
Request Sample of the Report on Nuclear Medicine Equipment Market Forecast 2034 – https://www.alliedmarketresearch.com/request-sample/A295002
Factors driving the growth of the kidney dialysis market
Rise in prevalence of chronic kidney disease and increase in awareness that promotes early diagnosis drive the expansion of the kidney dialysis sector. However, high treatment costs and limited access to dialysis services continue to restrict market growth. At the same time, technological innovations and expanding healthcare infrastructure in developing countries offer lucrative opportunities for market expansion in the coming years.
The hemodialysis segment held the largest share of the industry in 2023
By type, the hemodialysis segment generated the highest revenue in the kidney dialysis market in 2023. Hemodialysis is the most widely adopted dialysis method for patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). It effectively removes waste products and excess fluids from the blood, helping improve patient outcomes and quality of life. Its established infrastructure and clinical familiarity contribute to its continued market dominance.
The equipment segment dominated the genomics sector in 2023
By product and service, the equipment segment generated the highest revenue in the kidney dialysis market in 2023. Dialysis machines, water treatment systems, and related equipment are critical for delivering safe and efficient dialysis treatments. Continuous technological advancements, such as portable hemodialysis systems and automated monitoring, enhance treatment efficacy, driving demand for dialysis equipment in hospitals, clinics, and home-care settings.
The in-center dialysis segment accounted for a major share of the market in 2023
By end user, the in-center dialysis segment generated the highest revenue in the kidney dialysis market in 2023. Hospitals and specialized dialysis centers remain the primary settings for dialysis treatments due to the need for trained medical staff and advanced equipment. In-center dialysis ensures consistent monitoring and management of patients, making it a preferred choice, although home dialysis is gaining traction for convenience and patient autonomy.
Regional Outlook
From a regional perspective, North America and Europe are expected to maintain leadership in the kidney dialysis market, driven by robust healthcare infrastructure, established reimbursement policies, and high awareness of CKD. Asia-Pacific is projected to grow at a faster rate, fueled by expanding healthcare access, government initiatives, rising prevalence of kidney disorders, and increasing investments in dialysis infrastructure. LAMEA is also expected to witness gradual growth due to improving healthcare services and rising awareness of chronic kidney disease management.
Want to Explore More, Connect to our Analyst – https://www.alliedmarketresearch.com/connect-to-analyst/A295002
Key Players
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg SOURCE Allied Market Research
- Baxter International Inc.
- Nipro Corporation
- Diaverum Deutschland GmbH
- Asahi Kasei Corporation
- Fresenius Se And Co. KgAA
- B. Braun Melsungen AG
- Angiodynamics Inc.
- Becton, Dickinson and Company
- Davita, Nikkiso Co., Ltd.
- In July 2022, Baxter International Inc., a global innovator in renal care, and Ayogo Health Inc., a behavioral science-based digital health company, announced the expansion of their partnership to support the needs of patients with kidney disease through digital health solutions. Ayogo is combining LifePlan—its unique behavior-based digital platform—with Baxter’s expertise in renal care to build mobile apps and digital solutions that bring personalized, relevant and timely support to patients with kidney failure.
- In March 2022, B. Braun Melsungen AG announced that it has acquired Intermedt Medizin & Technik GmbH, a company that prepares dialysis concentrates. With this acquisition, Intermedt’s product portfolio was permanently integrated into B.Braun’s comprehensive range of products and services for dialysis therapy.
- In June 2023, Rockwell Medical, Inc, a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that the Company entered into a three-year co-promotion services agreement with B. Braun Medical Inc. (“B. Braun”), a leader in renal therapies including innovative, high-quality products for hemodialysis.
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg SOURCE Allied Market Research

Source link












Leave a Reply